Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5959177 | Heart Rhythm | 2016 | 18 Pages |
Abstract
In patients with an ICD, both AADs (amiodarone) and CA reduce the risk of recurrent VT compared to control medical therapy, with no significant difference between the 2 treatments. AADs are also associated with a reduction of inappropriate ICD therapies. The significant reduction of recurrent VT episodes does not appear to result in a mortality benefit, with a potential for increased mortality with amiodarone.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Pasquale MD, PhD, Daniele MD, Shingo MD, Annalisa MS, Erica S. PA-C, FHRS, David S. MD, FHRS, Sanjay MD, FHRS, Andrew E. MD, FHRS, David J. MD, FHRS, Francis E. MD, FHRS,